(Q86408467)

English

Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection

scientific article published on 13 March 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23499596%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23499596%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

active immunization

1 reference

based on heuristic

inferred from title

author name string

Yicun Cai

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23499596%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Qingwei Liu

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23499596%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Xulin Huang

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23499596%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Dapeng Li

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23499596%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Zhiqiang Ku

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23499596%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Yunfang Zhang

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23499596%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Zhong Huang

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23499596%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

publication date

13 March 2013

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23499596%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23499596%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

31

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23499596%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23499596%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

2215-2221

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23499596%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Human enterovirus 71 and hand, foot and mouth disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.007

7 January 2021

Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.007

7 January 2021

Genetic diversity of coxsackievirus A16 associated with hand, foot, and mouth disease epidemics in Japan from 1983 to 2003

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.007

7 January 2021

Molecular phylogeny of modern coxsackievirus A16.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.007

7 January 2021

Molecular evidence of persistent epidemic and evolution of subgenotype B1 coxsackievirus A16-associated hand, foot, and mouth disease in China.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.007

7 January 2021

Construction and characterization of an infectious clone of coxsackievirus A16.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.007

7 January 2021

Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.007

7 January 2021

Fatal infection in an infant associated with Coxsackie virus group A, type 16.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.007

7 January 2021

Myocarditis possibly due to Coxsackie group A, type 16, virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.007

7 January 2021

FATAL COXSACKIEVIRUS A16 INFECTION

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.007

7 January 2021

Fatal coxsackievirus A-16 pneumonitis in adult

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.007

7 January 2021

Rhombencephalitis and coxsackievirus A16

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.007

7 January 2021

Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.007

7 January 2021

Survey of enterovirus infections from hand, foot and mouth disease outbreak in China, 2009.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.007

7 January 2021

An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.007

7 January 2021

Emergence of enterovirus 71 "double-recombinant" strains belonging to a novel genotype D originating from southern China: first evidence for combination of intratypic and intertypic recombination events in EV71.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.007

7 January 2021

An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.007

7 January 2021

EV71: an emerging infectious disease vaccine target in the Far East?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.007

7 January 2021

Development of enterovirus 71 vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.007

7 January 2021

A neonatal mouse model of coxsackievirus A16 for vaccine evaluation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.007

7 January 2021

A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.007

7 January 2021

Quick identification of effective small interfering RNAs that inhibit the replication of coxsackievirus A16.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.007

7 January 2021

Development of murine monoclonal antibodies with potent neutralization effects on enterovirus 71.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.007

7 January 2021

The global polio eradication initiative: lessons learned and prospects for success

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.007

7 January 2021

Progress on the research and development of human enterovirus 71 (EV71) vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.007

7 January 2021

Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.007

7 January 2021

Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.007

7 January 2021

High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.007

7 January 2021

Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.03.007

7 January 2021

Identifiers

10.1016/J.VACCINE.2013.03.007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23499596%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23499596%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q86408467&oldid=1369037324"